Kilo Health is a leading digital health and wellness company founded in 2013, headquartered in Vilnius, Lithuania. It is recognized as the second fastest-growing company in Europe and Central Europe, with over 7 million customers worldwide, primarily in the United States. The company specializes in developing digital therapeutics and health management products that focus on chronic disease management, mental health, and overall wellness using advanced technologies such as AI, IoT, and VR.

Kilo Health offers a portfolio of more than 30 products designed to help people manage conditions like cholesterol, hypertension, diabetes, and gut health through digital platforms and behavioral science. Their solutions include apps for ketogenic dieting, intermittent fasting, cardiovascular health, and mental health support.

The company operates with a unique business model, creating and supporting multiple independent digital health startups through its Kilo Ventures program, which helps accelerate innovative products. Examples of their in-house developments include Klinio for diabetes management, Cardi.Health for cardiovascular care, and the popular intermittent fasting app DoFasting.

In addition to product development, Kilo Health fosters entrepreneurship with the Co-found program, aiding startups and visionaries in the digital health space. The company emphasizes continuous growth, both internally among its 500+ employees and externally by expanding access to effective digital health solutions globally.

Kilo Health has a strong commitment to leveraging cutting-edge technologies and behavioral science to provide scalable, accessible healthcare options that improve individuals’ quality of life and support healthier living.